News 28.04.2022 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that Amgen, its collaboration partner for MP0310 (AMG 506), has informed the...
News 21.04.2022 Schlieren (Zurich), Switzerland, April 21, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that its MagnetOs Flex Matrix has been cleared by the U.S. Food and Drug Administration (FDA) as a bone void filler for use in the posterolateral spine. MagnetOs Flex Matrix is...
News 13.04.2022 ZÜRICH, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of highly tumor-specific immuno-oncology therapeutics based on its proprietary antibody-based MHC-targeting T cell engager technology, today announced the closing of a $76 million Series A financing led by Jeito Capital and...
Events, Internal events
Event date: 03.05.2022
Do you have questions about possibilities to protect your invention, specific questions about current patent prosecution, or do you need advice regarding your IP portfolio? Join us for free counselling on May 03, 2022 in the rooms of Bio-Technopark Schlieren-Zürich at Wagistrasse 23 before the Networking Aperitif.
We are European patent...
Events, External events
Event date: 10.05.2022
10:00am–12:45pm CEST
A free, virtual event featuring European biotech founders, investors, scientists and industry experts who will share their strategies for lasting success.
There’s never been a better time to be part of a biotech startup. Yet, building a successful biotech company is no easy feat. Decisions you make early on can have...